Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6017591 | Experimental Neurology | 2014 | 12 Pages |
Abstract
In summary, these data highlight the role of central glial cells in oxaliplatin-dependent neuropathic pain. On the other hand, glial inhibition is not associated with neuroprotective effects suggesting the need for careful modulation of glial signaling to prevent the pathophysiology that leads to persistent neuropathic pain.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Lorenzo Di Cesare Mannelli, Alessandra Pacini, Laura Micheli, Alessia Tani, Matteo Zanardelli, Carla Ghelardini,